Evogene Granted Additional Time by Nasdaq to Regain Minimum Bid Price Compliance
Evogene (EVGN) has been granted an additional 180-day period by Nasdaq to regain compliance with the minimum bid price requirement. The company was notified on March 30, 2026 that it failed to meet the required closing bid for its shares over a previous 30 consecutive business days. This extension provides Evogene more time to address the issue before facing potential delisting from Nasdaq. Companies typically have options such as implementing reverse stock splits or improving their financial performance to regain compliance.
Tickers: $EVGN